2398-9238

Endocrinology Diabetes & Metabolism

Wiley (John Wiley & Sons)

View prefix report (10.1002)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 121 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact121 DOIs
2

Attach ORCID iDs across 121 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact121 DOIs
3

Deposit reference lists for 97 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact97 DOIs

DOIs for this ISSN

Showing the top 5 of 763 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Prevalence of diabetes and cardio‐metabolic risk factors in… (10.1002/edm2.81)
ORCID
37.28 30
2 Paediatric diabetes care during the COVID‐19 pandemic: Lesso… (10.1002/edm2.202)
Abstract
35.78 26
3 The relationships of sex hormone‐binding globulin, total tes… (10.1002/edm2.267)
ORCID
33.56 21
4 Exploring Connections Between Weight‐Loss Medications and Th… (10.1002/edm2.70038)
ORCID
31.38 17
5 Cover Image (10.1002/edm2.194)
Abstract References
30.10 3
6 One‐year safety and efficacy results of insulin treatment si… (10.1002/edm2.390)
ORCID
26.03 10
7 Healthcare experience among patients with type 2 diabetes: A… (10.1002/edm2.220)
ORCID
23.86 8
8 Expression of PD‐L1 in medullary thyroid carcinoma—a new the… (10.1002/edm2.241)
Abstract
22.58 7
9 The regulatory state of nonalcoholic steatohepatitis and met… (10.1002/edm2.113)
Abstract
21.13 6
10 Serum prolactin overestimation and risk of misdiagnosis (10.1002/edm2.65)
ORCID
21.13 6
11 Comparative Determination of Mitochondrial Biomarkers and Th… (10.1002/edm2.507)
ORCID
19.45 5
12 Improving Adherence to Treatment in Patients With Diabetes:… (10.1002/edm2.512)
Abstract
19.45 5
13 Spotlight on comorbidities in STEMI patients (10.1002/edm2.102)
Abstract
17.47 4
14 Impaired neuropsychological functioning in patients with hyp… (10.1002/edm2.165)
ORCID
17.47 4
15 Comment on IWGDF ulcer prevention guidelines (10.1002/edm2.169)
Abstract
17.47 4
16 Cover Image (10.1002/edm2.173)
Abstract References
15.05 1
17 Gestational Diabetes Mellitus and Risk Factors in a Multi‐Et… (10.1002/edm2.70005)
ORCID
15.05 3
18 NASH: Connecting the dots with patients in mind (10.1002/edm2.109)
Abstract
11.93 2
19 Characteristics of hypoglycaemic episodes in diabetic patien… (10.1002/edm2.150)
ORCID
11.93 2
20 Confluence of obesity and MAFLD during Covid‐19 pandemic in… (10.1002/edm2.189)
Abstract
11.93 2
21 <i>MYC</i> mRNA expression throughout the intestine is not a… (10.1002/edm2.327)
Abstract
11.93 2
22 Diabetic Kidney Disease Progression Alleviated in Mice by AL… (10.1002/edm2.70131)
ORCID
11.93 2
23 Effects of sodium‐glucose cotransporter 2 inhibitors on hypo… (10.1002/edm2.44)
ORCID
7.53 1
24 Pancreatic safety of vildagliptin in patients with type 2 di… (10.1002/edm2.52)
ORCID
7.53 1
25 Women Suffered More Than Men Both During and After the COVID… (10.1002/edm2.70004)
ORCID
7.53 1
26 Predicting Time in Range Without Hypoglycaemia Using a Risk… (10.1002/edm2.70020)
ORCID
7.53 1
27 Commentary on “Are Individuals With Type 2 Diabetes Metaboli… (10.1002/edm2.70068)
Abstract
7.53 1
28 Association Between Hepatic Steatosis and Deterioration of M… (10.1002/edm2.70156)
ORCID
7.53 1
29 A journal for the modern era (10.1002/edm2.1)
Abstract References
0.00 0
30 MALAT1: A regulator of inflammatory cytokines in diabetic co… (10.1002/edm2.10)
0.00 41
31 Risk of any hypoglycaemia with newer antihyperglycaemic agen… (10.1002/edm2.100)
0.00 7
32 Circadian‐timed quick‐release bromocriptine lowers elevated… (10.1002/edm2.101)
0.00 11
33 The EMPagliflozin compaRative effectIveness and SafEty (EMPR… (10.1002/edm2.103)
0.00 29
34 Serum C‐peptide and osteocalcin levels in children with rece… (10.1002/edm2.104)
0.00 8
35 Drug discovery and treatment paradigms in nonalcoholic steat… (10.1002/edm2.105)
0.00 45
36 The prevalence of cardiovascular disease by vascular bed and… (10.1002/edm2.106)
0.00 7
37 Dose distribution and up‐titration patterns of metformin mon… (10.1002/edm2.107)
0.00 7
38 The impact of phenotype, ethnicity and genotype on progressi… (10.1002/edm2.108)
0.00 22
39 Severity of hypoglycaemia and health‐related quality of life… (10.1002/edm2.11)
0.00 15
40 Liver disease, the Swiss army knife of comorbidity: A patien… (10.1002/edm2.110)
Abstract References
0.00 0
41 Trauma exposure and stress‐related disorders in African‐Amer… (10.1002/edm2.111)
0.00 16
42 The metabolic basis of nonalcoholic steatohepatitis (10.1002/edm2.112)
0.00 78
43 Cardiovascular risk factor control in British adults with di… (10.1002/edm2.114)
0.00 2
44 Quality of life is not affected by thyroid surgery in nontox… (10.1002/edm2.115)
0.00 11
45 Prevalence of elevated liver enzymes and its association wit… (10.1002/edm2.116)
0.00 53
46 Prolonged glucosuria and relapse of diabetic ketoacidosis re… (10.1002/edm2.117)
0.00 12
47 The impact of coenzyme Q<sub>10</sub> on metabolic and cardi… (10.1002/edm2.118)
0.00 41
48 Assessment of lipid response to acute olanzapine administrat… (10.1002/edm2.119)
0.00 4
49 Issue Information (10.1002/edm2.12)
Abstract References ORCID
0.00 0
50 Pre‐empting the challenges faced in adolescence: A systemati… (10.1002/edm2.120)
0.00 2